IL-4, IL-13 and other type 2 cytokines have long been known to be drivers of allergic asthma [29, 30], and many studies have shown increased chemokine levels in the airways of patients with asthma compared to controls [31–39]. This evidence concerns the gene IL4 and allergic asthma.